|
What
are viral hemorrhagic fevers?
Researchers wearing protective clothing
investigate the 1993 HPS outbreak
Viral hemorrhagic fevers (VHFs) refer to a group of illnesses that
are caused by several distinct families of viruses. In general,
the term "viral hemorrhagic fever" is used to describe
a severe multisystem syndrome (multisystem in that multiple organ
systems in the body are affected). Characteristically, the overall
vascular system is damaged, and the body's ability to regulate itself
is impaired. These symptoms are often accompanied by hemorrhage
(bleeding); however, the bleeding is itself rarely life-threatening.
While some types of hemorrhagic fever viruses can cause relatively
mild illnesses, many of these viruses cause severe, life-threatening
disease.
How are hemorrhagic
fever viruses grouped?
VHFs
are caused by viruses of four distinct families: arenaviruses, filoviruses,
bunyaviruses, and flaviviruses.
Each of these families share a number of features:
-They are all RNA viruses, and all are covered, or enveloped,
in a fatty (lipid) coating.
-Their survival is dependent on an animal or insect
host, called the natural reservoir.
-The viruses are geographically restricted to the areas
where their host species live.
-Humans are not the natural reservoir for any of these
viruses. Humans are infected when they come into contact
with infected hosts. However, with some viruses, after the accidental
transmission from the host, humans can transmit the virus
to one another.
-Human cases or outbreaks of hemorrhagic fevers caused
by these viruses occur sporadically and irregularly.
-The occurrence of outbreaks cannot be easily predicted.
-With a few noteworthy exceptions, there is no cure
or established drug treatment for VHFs.
-In rare cases, other viral and bacterial infections
can cause a hemorrhagic fever; scrub typhus is a good example.
What
carries viruses that cause viral hemorrhagic fevers?
Viruses associated with most
VHFs are zoonotic. This means that these viruses naturally reside
in an animal reservoir host or arthropod vector. They are totally
dependent on their hosts for replication and overall survival. For
the most part, rodents and arthropods are the main reservoirs for
viruses causing VHFs. The multimammate rat, cotton rat, deer mouse,
house mouse, and other field rodents are examples of reservoir hosts.
Arthropod ticks and mosquitoes serve as vectors for some of the
illnesses. However, the hosts of some viruses remain unknown --
Ebola and Marburg viruses are well-known examples.
Where
are cases of viral hemorrhagic fever found?
Taken together, the viruses that
cause VHFs are distributed over much of the globe. However, because
each virus is associated with one or more particular host species,
the virus and the disease it causes are usually seen only where
the host species live(s). Some hosts, such as the rodent species
carrying several of the New World arenaviruses, live in geographically
restricted areas. Therefore, the risk of getting VHFs caused by
these viruses is restricted to those areas. Other hosts range over
continents, such as the rodents that carry viruses which cause various
forms of hantavirus pulmonary syndrome (HPS) in North and South
America, or the different set of rodents that carry viruses which
cause hemorrhagic fever with renal syndrome (HFRS) in Europe and
Asia. A few hosts are distributed nearly worldwide, such as the
common rat. It can carry Seoul virus, a cause of HFRS; therefore,
humans can get HFRS anywhere where the common rat is found.
While people usually become infected
only in areas where the host lives, occasionally people become infected
by a host that has been exported from its native habitat. For example,
the first outbreaks of Marburg hemorrhagic fever, in Marburg and
Frankfurt, Germany, and in Yugoslavia, occurred when laboratory
workers handled imported monkeys infected with Marburg virus. Occasionally,
a person becomes infected in an area where the virus occurs naturally
and then travels elsewhere. If the virus is a type that can be transmitted
further by person-to-person contact, the traveler could infect other
people. For instance, in 1996, a medical professional treating patients
with Ebola hemorrhagic fever (Ebola HF) in Gabon unknowingly became
infected. When he later traveled to South Africa and was treated
for Ebola HF in a hospital, the virus was transmitted to a nurse.
She became ill and died. Because more and more people travel each
year, outbreaks of these diseases are becoming an increasing threat
in places where they rarely, if ever, have been seen before.
How
are hemorrhagic fever viruses transmitted?
Viruses causing hemorrhagic fever
are initially transmitted to humans when the activities of infected
reservoir hosts or vectors and humans overlap. The viruses carried
in rodent reservoirs are transmitted when humans have contact with
urine, fecal matter, saliva, or other body excretions from infected
rodents. The viruses associated with arthropod vectors are spread
most often when the vector mosquito or tick bites a human, or when
a human crushes a tick. However, some of these vectors may spread
virus to animals, livestock, for example. Humans then become infected
when they care for or slaughter the animals.
Some viruses that cause hemorrhagic
fever can spread from one person to another, once an initial person
has become infected. Ebola, Marburg, Lassa and Crimean-Congo hemorrhagic
fever viruses are examples. This type of secondary transmission
of the virus can occur directly, through close contact with infected
people or their body fluids. It can also occur indirectly, through
contact with objects contaminated with infected body fluids. For
example, contaminated syringes and needles have played an important
role in spreading infection in outbreaks of Ebola hemorrhagic fever
and Lassa fever.
What
are the symptoms of viral hemorrhagic fever illnesses?
Specific signs and symptoms vary
by the type of VHF, but initial signs and symptoms often include
marked fever, fatigue, dizziness, muscle aches, loss of strength,
and exhaustion. Patients with severe cases of VHF often show signs
of bleeding under the skin, in internal organs, or from body orifices
like the mouth, eyes, or ears. However, although they may bleed
from many sites around the body, patients rarely die because of
blood loss. Severely ill patient cases may also show shock, nervous
system malfunction, coma, delirium, and seizures. Some types of
VHF are associated with renal (kidney) failure.
How
are patients with viral hemorrhagic fever treated?
Patients receive supportive therapy,
but generally speaking, there is no other treatment or established
cure for VHFs. Ribavirin, an anti-viral drug, has been effective
in treating some individuals with Lassa fever or HFRS. Treatment
with convalescent-phase plasma has been used with success in some
patients with Argentine hemorrhagic fever.
How
can cases of viral hemorrhagic fever be prevented and controlled?
With the exception of yellow
fever and Argentine hemorrhagic fever, for which vaccines have been
developed, no vaccines exist that can protect against these diseases.
Therefore, prevention efforts must concentrate on avoiding contact
with host species. If prevention methods fail and a case of VHF
does occur, efforts should focus on preventing further transmission
from person to person, if the virus can be transmitted in this way.Because
many of the hosts that carry hemorrhagic fever viruses are rodents,
disease prevention efforts include: controlling rodent populations;
discouraging rodents from entering or living in homes or workplaces;
encouraging safe cleanup of rodent nests and droppings.
For hemorrhagic fever viruses spread
by arthropod vectors, prevention efforts often focus on community-wide
insect and arthropod control. In addition, people are encouraged
to use insect repellant, proper clothing, bednets, window screens,
and other insect barriers to avoid being bitten.
For those hemorrhagic fever viruses
that can be transmitted from one person to another, avoiding close
physical contact with infected people and their body fluids is the
most important way of controlling the spread of disease. Barrier
nursing or infection control techniques include isolating infected
individuals and wearing protective clothing. Other infection control
recommendations include proper use, disinfection, and disposal of
instruments and equipment used in treating or caring for patients
with VHF, such as needles and thermometers.
In conjunction with the World Health
Organization, CDC has developed practical, hospital-based guidelines,
titled Infection Control for Viral Haemorrhagic Fevers In the African
Health Care Setting. The manual can help health-care facilities
recognize cases and prevent further hospital-based disease transmission
using locally available materials and few financial resources.
All
information obtained from the CDC
(Center for Disease Control and Prevention)
|